APP and Alzheimer disease: Using a new method to specifically decelerate TL shortening in the cortex and myocardial tissue can effectively improve cognitive performance in a mouse model of AD (APP/PS1) (Zhang et al., 2023), suggesting TL is indeed a determinant of AD.